(HTR) is responsible for the increase of ovarian cancer
A new English study is being published today in The Lancet about that the use of hormone replacement therapy (HTR) by women, increases risk of ovarian cancer. This study attributes 1,000 extra ovarian cancer deaths in the UK since 1991 to HRT. Those who were treated for at least five years, were on average 23% more likely to die of ovarian cancer than those who had never used HRT.
For every 1,000 HRT users, 1.6 women died compared with 1.3 non-users. This amounted to one extra ovarian cancer death in roughly 3,300 users, said Valerie Beral, MBBS, of the Cancer Research United Kingdom Epidemiology Unit.
Not only HRT affects ovarian cancer, Dr. Beral said, but it also affects the risk of breast and endometrial cancer. In total, these three cancers account for 39% of all cancers in women in Britain.
These data add to the message that we really should be discouraging women from initiating menopausal hormones," said Marcia L. Stefanick of Stanford University.
With this new research we hope that the use of HRT falls further and the number of women dying of ovarian cancer declines, as well.
This article was submitted by Thomas Stevens. Thomas is also one of the main writers on A.B.B.4 and has published many articles to do with botox for sweating.